Ilika and Cirtec Medical have announced that they have signed a 10-year manufacturing licence to produce the Stereax range of mm-scale batteries at Cirtec’s facility in Lowell, USA.
Ilika, which is based in Romsey, UK, develops solid-state batteries, which can be used in a range of applications including cardiac sensing, neurostimulation and smart orthopaedics. The company has said it will continue to focus on advanced technology development and intellectual property (IP) licensing in support of Cirtec’s manufacturing and commercialisation activities.
Graeme Purdy, Ilika’s chief executive officer, said: “We are delighted to be working with Cirtec for the commercialisation of Stereax. Cirtec has a strong track record in the commercialisation of miniature medical devices and we believe this partnership is well-positioned to ensure a high quality, reliable and scalable supply of Stereax batteries to our customers.”
Brian Highley, Cirtec Medical chief executive officer, commented: “We are excited by the prospect of adding Stereax battery technology to our portfolio of medical device solutions. Our 20 years of experience in the design, development and manufacture of medical devices positions Cirtec strongly to work with Ilika to bring its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets.”
